United States· US:82442-401_42f3ff91-2b4d-ec25-e063-6294a90a250e
Calamine Plus Pramoxine HCl
A medicinal product containing ferric oxide red; pramoxine hydrochloride; zinc oxide, registered in United States by Target Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE
- Manufacturer
- Target Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 26, 2026
Packs & prices · 2
- ndc118244240101116 g in 1 CAN (82442-401-01)
- ndc1182442-401-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9b18d218-93ba-46bc-b61a-f4e0d8b08cf9 GET /v1/drugs/9b18d218-93ba-46bc-b61a-f4e0d8b08cf9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "5; 10; 75",
"substance": "FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE",
"productndc": "82442-401",
"dosage_form": "AEROSOL, SPRAY",
"dea_schedule": null,
"strength_unit": "mg/g; mg/g; mg/g",
"application_number": "M017",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about ferric oxide red; pramoxine hydrochloride; zinc oxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.